ID   AICHI-4
AC   CVCL_5G39
DR   Wikidata; Q54748991
RX   PubMed=5728341;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a B-lymphoblastoid cell line (PubMed=29533902).
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=5728341).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000027.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
RX   PubMed=5728341; DOI=10.1093/jnci/41.6.1367;
RA   Ito Y., Shiratori O., Kurita S., Takahashi T., Kurita Y., Ota K.;
RT   "Some characteristics of a human cell line (AICHI-4) established from
RT   tumorous lymphatic tissue of Hodgkin's disease.";
RL   J. Natl. Cancer Inst. 41:1367-1375(1968).
//
RX   PubMed=29533902; DOI=10.1515/hsz-2017-0321;
RA   Drexler H.G., Pommerenke C., Eberth S., Nagel S.;
RT   "Hodgkin lymphoma cell lines: to separate the wheat from the chaff.";
RL   Biol. Chem. 399:511-523(2018).
//